Citation Impact
Citing Papers
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
2009
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz)
1998 Standout
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
The role of HER2 in cancer therapy and targeted drug delivery
2010
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines
2006
Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy
2012
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Geriatric cachexia: the role of cytokines
1999
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
The long‐term effect of pinealectomy on the crypts of the rat gastrointestinal tract
1995
Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin
1993
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Update on anorexia and cachexia
2002
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Melatonin and Breast Cancer: A Prospective Study
2004
Definition and classification of cancer cachexia: an international consensus
2011 Standout
In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line
2000
Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants
2001
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Distribution, function and physiological role of melatonin in the lower gut
2011
Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice
2004 Standout
Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery
1999
Cancer-associated cachexia
2018 Standout
A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients
2010
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2018
Pyroptosis: mechanisms and diseases
2021 Standout
Combinations of Bevacizumab With Cancer Immunotherapy
2018
Catalytic Functionalization of Indoles in a New Dimension
2009 Standout
Ageing and infection
2002 Standout
Cytokine patterns in patients with cancer: a systematic review
2013 Standout
Mechanisms and functional significance of tumour-induced dendritic-cell defects
2004
Male breast cancer
2006 Standout
Cachexia in cancer patients
2002
Antioxidant Properties of Melatonin and its Potential Action in Diseases
2015
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
2009
Photodynamic therapy and anti-tumour immunity
2006 Standout
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer
2011
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
2008
A Review of the Multiple Actions of Melatonin on the Immune System
2005
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression
2006
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
2021
Origin and physiological roles of inflammation
2008 StandoutNature
2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists
1998
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
2002
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway
2006
Immature myeloid cells and cancer-associated immune suppression
2002
Cancer-related inflammation
2008 StandoutNature
Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine
2013
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair
2008
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages
2005
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways
2005
Meditation, melatonin and breast/prostate cancer: Hypothesis and preliminary data
1995
Exosomes: composition, biogenesis and function
2002 Standout
REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance
2002 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
2005
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression
2004
The Complex Role of Estrogens in Inflammation
2007 Standout
Prognostic significance of CD4/CD8 ratio in patients with advanced cervical cancer
2019
Cryptochrome: The Second Photoactive Pigment in the Eye and Its Role in Circadian Photoreception
2000 StandoutNobel
Light Pollution as a New Risk Factor for Human Breast and Prostate Cancers
2013
Vascular Endothelial Growth Factor-Trap Overcomes Defects in Dendritic Cell Differentiation but Does Not Improve Antigen-Specific Immune Responses
2007
Increased serum transforming growth factor-β1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration
2003
The Melatonin Hypothesis: Electric Power and Breast Cancer
1996
Dendritic Cells and Tumor Microenvironment: A Dangerous Liaison
2006
Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
2005
Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
2005
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Systematic Review of the Treatment of Cancer-Associated Anorexia and Weight Loss
2005
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Antioxidants in cancer therapy; their actions and interactions with oncologic therapies.
1999
The new world atlas of artificial night sky brightness
2016 Standout
The melatonin hypothesis: electric power and breast cancer.
1996
The mammary gland
1991
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
1999
Melatonin involvement in immunity and cancer
1998
Mindfulness training as a clinical intervention: A conceptual and empirical review.
2003 Standout
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Endogenous Melatonin Increases in Cerebrospinal Fluid of Patients after Severe Traumatic Brain Injury and Correlates with Oxidative Stress and Metabolic Disarray
2008
Works of F Brivio being referenced
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract
1993
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma
1994
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
1996
Pineal Gland and Tumor Cell Kinetics: Serum Levels of Melatonin in Relation to Ki-67 Labeling Rate in Breast Cancer
1990
Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin
1996
Is there a role for melatonin in the treatment of neoplastic cachexia?
1996
Phenotype and function of dendritic cells and T-lymphocyte polarization in the human colonic mucosa and adenocarcinoma
2008
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
2009
A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.
2000
Efficacy of Cancer Chemotherapy in Relation to the Pretreatment Number of Lymphocytes in Patients with Metastatic Solid Tumors
2004
The Pineal Gland and Breast Cancer: Serum Levels of Melatonin in Patients with Mammary Tumors and Their Relation to Clinical Characteristics
1989
A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients.
2008
Melatonin as a new possible anti-inflammatory agent.
1998
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients.
1993
Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients.
1996
Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancer.
1993
EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS
1995
Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
2007
Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin.
1995
Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancer
2003
Circulating Immature and Mature Dendritic Cells in Relation to Lymphocyte Subsets in Patients with Gastrointestinal Tract Cancer
2000
Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease.
2001
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
2002
Changes in Circulating VEGF Levels in Relation to Clinical Response during Chemotherapy for Metastatic Cancer
2003